Intrathecal release of pro- and anti-inflammatory cytokines during stroke

Clinical and Experimental Immunology

Volumn 110, Issue 3, 1997, Pages 492-499

  Tarkowski, E ^a   Rosengren, L ^a   Blomstrand, C ^a   Wikkelso C ^a   Jensen, C ^a   Ekholm, S ^a   Tarkowski, A ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Cerebrospinal fluid; Granulocyte macrophage colony stimulating factor; IL 10; IL 8; Magnetic resonance imaging brain; Tumour necrosis factor

Indexed keywords

CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PRIORITY JOURNAL; STROKE;

EID: 0030732630     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.4621483.x     Document Type: Article

References (50)

1. Kogure K, Kato H. Neurochemislry of stroke. In: Barnett HJM, Mohr JP, Stein BM, Yatsu FM, eds. Stroke. Pathophysiology, diagnosis, and management, 2nd edn. New York: Churchill Livingstone, 1992:3-28.
2. Siesjö BK. A new perspective on ischemic brain damage? In: Kogure K, Hossman KA, Siesjö BK, eds. Neurobiology of ischemic brain damage. Prog Brain Res 1993; 96:1-12.
3. Diemer NH, Valente K, Bruhn T, Berg M, Jörgensen MB, Johansen FF. Glutamate receptor transmission and ischemic nerve cell damage: evidence for involvement of excitotoxic mechanisms. In: Kogure K, Hossman KA, Siesjö BK, eds. Neurobiology of ischemic brain damage. Prog Brain Res 1993; 96:105-24.
4. Watson BD. Evaluation of the concomitance of lipid peroxidation in experimental models of cerebral ischemia and stroke. In: Kogure K, Hossman KA, Siesjö BK, eds. Neurobiology of ischemic brain damage. Prog Brain Res 1993; 96:69-96.
5. Kochanek PM, Hallebheck JM. Polymorphonuclear leukocytes and monocytes/macrophages in the pathogenesis of cerebral ischemia and stroke. Stroke 1992; 23:1367-79.
6. Hallenbeck JM, Dutka AJ. Bakgrund review and current concept of reperfusion injury. Arch Neurol 1990; 47:1245-54.
7. Schrocter M, Jander S, Witte OW, Stoll G. Local immune responses in the rat cerebral cortex alter middle cerebral artery occlusion. J Neuroimmunol 1994; 55:195-203.
8. Wang X, Yue T-L, Barone FC, Feuerstein GZ. Demonstration of increased endothelial-leukocyte adhesion molecule-1 mRNA expression in rat ischemic cortex. Stroke 1995; 26:1665-9.
9. Shiga Y, Onodera H, Kogure K, Yamasaki Y, Yashima Y, Syozyhara H, Sendo F. Neutrophil as mediator of ischemic edema formation in the brain. Neuroscience Letters 1991; 125:110-2.
10. Connolly ES, Winfree CJ, Springer TA et al. Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J Clin Invest 1996; 97:209-16.
11. Gross CE, Howard DB, Dooley RH, Raymond SJ, Fuller S, Bednar MM. TGF-β1 post-treatment in a rabbit model of cerebral ischaemia. Neurol Res 1994; 16:465-70.
12. Iadecola C, Zhang F, Xu X. Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am J Physiol 1995; 268:R286-R292.
13. Tarkowski E, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, Tarkowski A. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke 1995; 26:1393-8.
14. Scandinavian Stroke Study Group. Multicentral trial of hemodilution in ischemic stroke: background and study protocol. Stroke 1985; 16: 885-90.
15. Mahoney FI, Barthel DW. Functional evaluation: The Barthel Index. Md State Med J 1965; 24:61-69.
16. Hachinski V. Classification of stroke for clinical trials. Stroke 1990; 21:27-29.
17. Blomstrand C, Olsson JH, Nilsson B et al. Swedish aspirin low-dose trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events. Lancet 1991; 338:1345-9.
18. Kretschmann HJ, Weinrich V. Cranial neuroimaging and clinical anatomy, 2nd edn. Stuttgart: Thieme, 1992; 1-100.
19. Aloisi F, Care A, Borsellino G et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony stimulating factors) by normal human astrocytes in response to IL-1β and tumor necrosis factor-α. J Immunol 1992; 149:2358-66.
20. Nitta T, Allegretta M, Okumura K, Sato K, Steiman L. Neoplastic and reactive human astrocytes express interleukin-8 gene. Neurosurg Rev 1992; 15:203-7.
21. Malipiero UV, Frei K, Fontana A. Production of hemopoietic colony-stimulating factors by astrocytes. J Immunol 1990; 144:3816-21.
22. Ohno K, Suzumura S, Sawada M, Marunouchi T. Production of granulocyte/macrophage colony-stimulating factor by cultured astrocytes. Biochem Biophys Res Commun 1990; 169:719-24.
23. Clark RK, Lee EV, Fish CJ, White RF, Price WJ, Jonak ZL, Feuerstein GZ, Barone FC. Development of tissue damage, inflammation and resolution following stroke: an immunohistochemical and quantitative Planimetric study. Brain Res Bull 1993; 31:565-72.
24. Huettner C, Paulus W, Roggendorf W. Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol 1995; 146:317-22.
25. Schröder JM, Mrowietz U, Morita E, Christophers E. Purification and partial biochemical characterization of a human monocyte-derived, neutrophil activating peptide that lacks interleukin-1 activity. J Immunol 1987; 139:3474-83.
26. Huber AR, Kunkel SL, Todd RF. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991; 254:99-102.
27. Smith WB, Gamble JR, Clark-Lewis I, Vadas MA. Interleukin-8 induces neutrophil transendothelial migration. Immunology 1991; 72:65-72.
28. Detmers PA, Powell DE, Walz A, Clark-Lewis I, Baggiolini M, Cohn ZA. Differential effect of neutrophil activating peptide 1/IL-8 on leukocyte adhesion and phagocytosis. J Immunol 1991; 147:4211-7.
29. Foster SJ, Aked DM, Schröder JM, Christophers E. Acute inflammatory effects of a monocyte-derived neutrophil-activating peptide in rabbit skin. Immunology 1989; 67:181-3.
30. DeForge LE, Tracey DE, Kenney JS, Remick DG. Interleukin-1 receptor antagonist protein inhibits interleukin-8 expression in lipopolysaccharide-stimulated human whole blood. Am J Pathol 1992; 140:1045-54.
31. Relton JK, Rothwell NL. Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res Bull 1992; 29:243-6.
32. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Einer SG, Stricter RM. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science 1992; 258:1798-801.
33. Krupinski J, Kalusa J, Kumar P, Kumar S, Wang JM. Role of angiogenesis in patients with cerebral ischemic stroke. Stroke 1994; 25:1794-8.
34. Marchal G, Serrari C, Rioux P. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: relation to the outcome. Lancet 1993; 341:925-7.
35. Araujo DM, Cotman CW. Trophic effects of interleukin-4, -7, and -8 on hippocampal neural cultures: potential involvement glial-derived factors. Brain Res 1993; 600:49-55.
36. Araujo DM, Cotman CW. Differential effect of interleukin-1β and interleukin-2 on glia and hippocampal neurons in culture. Int J Devl Neuroscience 1995; 13:201-12.
37. Rasko JE, Cough NM. Granulocyte-macrocyte colony stimulating factor. In: Thomson AW, ed. The cytokine handbook, 2nd edn. London: Academic Press. 1994; 19:343-69.
38. Giulian D, Li J, Li X, George J, Rutecki PA. The impact of microglial-derived cytokines upon gliosis in the CNS. Dev Neurosci 1994; 16:128-36.
39. Gehrmann J. Colony-stimulating factors regulate programmed cell death of rat microglia/brain macrophages in vitro. J Neuroimmunol 1995; 63:55-61.
40. Baldwin GC, Benveniste EN, Chung GY, Gasson JC, Golde DW. Identification and characterization of a high-affinity granulocyte-macrophage colony Stimulating factor receptor on primary rat oligodendrocytes. Blood 1993; 82:3279-82.
41. Smith ME. Phagocytosis of myelin by microglia in vitro. J Neurosci Res 1993; 35:480-7.
42. Mossman TR. Interleukin-10. In: Thomson AW. ed. The cytokine handbook, 2nd edn. London: Academic Press. 1994; 12:223-37.
43. Frei K, Lins H, Schwerdel C, Fontana A. Antigen presentation in the central nervous system: the inhibitory effect of IL-10 on MHC class II expression and production of cytokines depends on the inducing signals and the type of cell analyzed. J Immunol 1994; 152:2720-8.
44. Benveniste EN, Tang LP, Law RM. Differential regulation of astrocyte TNF-α expression by the cytokines TGF-β, IL-6 and 1L-10. Int J Devl Neuroscience 1995; 13:341-9.
45. Wang XK, Yue T-L, Barone FC, White RF, Young PR, McDonell PC, Feuerstein GZ. Concomitant cortical expression of TNF-α and IL-1β m-RNA following focal ischemia. Mol Chem Neuropathol 1994; 23:103-14.
46. Selmaj KW, Raine CS. Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 1988; 23:339-46.
47. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB 1992; 6:3051-64.
48. Piani D, Spranger M, Frei K, Schaffner A, Fontana A. Macrophage-induced cytotoxicity of N-methyl-D-aspartate receptor positive neurons involves excitatory aminoacids rather than reactive oxygen intermediates and cytokines. Eur J Immunol 1992; 22:2429-36.
49. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxid mechanism. J Immunol 1992; 149:2736-41.
50. Talley AK, Dewhurst S, Perry SW et al. Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: protection by the anti-oxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 1995; 15:2359-66.